search
Back to results

Physica System Total Knee Replacement Registry Study

Primary Purpose

Osteoarthritis, Knee, Traumatic Arthritis, Avascular Necrosis

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Physica Kinematic Retaining Knee System
Physica Cruciate Retaining Knee System
Physica Posterior Stabilized Knee System
Physica Cruciate Retaining Knee System with LMC Liner
Sponsored by
Limacorporate S.p.a
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Physica KR, Physica CR, Physica PS, Kinematic Retaining, Cruciate Retaining, Posterior Stabilized, Physica System

Eligibility Criteria

22 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Males and females of any race requiring a total knee replacement and suitable for the use of one of the configurations of the Physica system
  2. Age> 22 (skeletally mature)
  3. Patients who are suffering from non-inflammatory degenerative joint disease (NIDJD): including knee osteoarthritis, post-traumatic knee arthritis; or patients who are suffering from inflammatory arthritis; or patients that need correction of a functional deformity
  4. Suitable candidates for TKR who have undamaged and functional collateral ligaments
  5. Suitable candidates for TKR with Physica KR and CR who have an undamaged and functional posterior cruciate ligament; or suitable candidates for TKR using Physica PS with an absent or not-functioning posterior cruciate ligament and/or severe antero-posterior instability of the knee joint and received the study device at the time of surgery
  6. Patients who understand the conditions of the study and are willing and able to comply with the prescribed rehabilitation and to perform all scheduled follow-up visits
  7. Patients who have signed the Ethics Committee/IRB approved study-specific Informed Consent Form prior to the surgery

Exclusion Criteria:

  1. Patients with severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function
  2. Patients with active or any suspected infection (on the affected knee or systemic)
  3. Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy
  4. Patients with significant bone loss on femoral or tibial joint side
  5. Current treatment for malignant and/or life-threatening non-malignant disorders
  6. Patients with known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials
  7. Vascular insufficiency of lower limbs severe enough to interfere with the study evaluation
  8. Patients with bone stock compromised by disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis
  9. Patients with systemic or metabolic disorders leading to progressive bone deterioration which may impair fixation and stability of the implant
  10. Any concomitant disease and dependence that might affect the performance of the implanted prosthesis
  11. Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation (e.g. primary osteoporosis with significant bone loss, haemophilic disease, septicaemia, persistent acute or chronic osteomyelitis)
  12. Patients who have significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery and evaluation
  13. Patients who have neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device
  14. Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint
  15. Any psychiatric illness that would prevent comprehension of the details and nature of the study
  16. Patients currently participating in any other surgical intervention studies or pain management studies
  17. Female patients who are pregnant, nursing, or planning a pregnancy

Sites / Locations

  • Eisenhower Desert Orthopedics Center - Harry and Diane Rinker BldgRecruiting
  • The Orthopedics ClinicRecruiting
  • Rush Castle OrthopaedicsRecruiting
  • Syracuse Orthopedic Specialists
  • Joint Reconstructive Specialist

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Other

Other

Other

Other

Arm Label

Physica KR

Physica CR

Physica PS

Physica CR with LMC Liner

Arm Description

Subjects that receive the Physica Kinematic Retaining Knee System

Subjects that receive the Physica Cruciate Retaining Knee System

Subjects that receive the Physica Posterior Stabilized Knee System

Subjects that receive the Physica Cruciate Retaining Knee System with LMC Liner

Outcomes

Primary Outcome Measures

Implant Survivorship
The primary endpoint is the definition of the implant survivorship of the study device to 10 years after the total knee replacement surgery.

Secondary Outcome Measures

American Knee Society Score (KSS) 2011
Clinical performance assessment measured by overall pain and functionality from baseline to 10-year follow-up
Patient-Reported Outcome Measures (PROMs)
Patient-Reported Outcome Measures (PROMs) including patient satisfaction achievement from baseline to 10-year follow-up
Radiographic Evaluation
• Radiographic implant evaluation and stability assessment from baseline to 10-year follow-up

Full Information

First Posted
February 7, 2017
Last Updated
March 17, 2023
Sponsor
Limacorporate S.p.a
search

1. Study Identification

Unique Protocol Identification Number
NCT03048201
Brief Title
Physica System Total Knee Replacement Registry Study
Official Title
Post-market Registry Study on the Physica System Total Knee Replacement
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 24, 2017 (Actual)
Primary Completion Date
March 2030 (Anticipated)
Study Completion Date
March 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Limacorporate S.p.a

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.
Detailed Description
This is a post-market registry study; the study device is FDA cleared and used according to the intended use. This is a multi-centre, prospective, non-randomized study. Subjects will be implanted with one of the following configurations of the Physica system: Physica KR (Kinematic Retaining), Physica CR (Cruciate Retaining) or Physica PS (Posterior Stabilized). The assignment of any patient involved in the study is determined by the aetiology preoperatively evaluated by the Investigator and falls within current practice. The decision to use a specific prosthesis design is decided by the Investigators independently and clearly separated from the decision to include the patient in the study. For the ancillary subgroup, investigators currently contributing to the primary patient group can also enroll additional patients to the ancillary subgroup. 3 existing sites and 2 additional sites are planned to be added to contribute to the additional 300 patients to be enrolled. These patients will follow the same study schedules as the main study, but follow-up is only up to 5 years. Baseline measurements (pre-operative clinical analysis and radiographic analysis at 6-week FU) will serve as internal control term during the assessment of post-surgery data out to 10 years.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee, Traumatic Arthritis, Avascular Necrosis, Degenerative Joint Disease of Knee, Rheumatoid Arthritis, Deformity of Knee
Keywords
Physica KR, Physica CR, Physica PS, Kinematic Retaining, Cruciate Retaining, Posterior Stabilized, Physica System

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Subjects will receive a commercially available Physica system total knee replacement in one of 3 different configurations: KR (Kinematic Retaining), CR (Cruciate Retaining) and PS (Posterior Stabilized). The assignment of any patient involved in the study is determined by the aetiology preoperatively evaluated by the Investigator and falls within current practice.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
800 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Physica KR
Arm Type
Other
Arm Description
Subjects that receive the Physica Kinematic Retaining Knee System
Arm Title
Physica CR
Arm Type
Other
Arm Description
Subjects that receive the Physica Cruciate Retaining Knee System
Arm Title
Physica PS
Arm Type
Other
Arm Description
Subjects that receive the Physica Posterior Stabilized Knee System
Arm Title
Physica CR with LMC Liner
Arm Type
Other
Arm Description
Subjects that receive the Physica Cruciate Retaining Knee System with LMC Liner
Intervention Type
Device
Intervention Name(s)
Physica Kinematic Retaining Knee System
Intervention Description
Modular total knee prosthesis with a Kinematic Retaining mechanism and posterior cruciate ligament (PCL) preservation
Intervention Type
Device
Intervention Name(s)
Physica Cruciate Retaining Knee System
Intervention Description
Total knee prosthesis with posterior cruciate ligament (PCL) preservation
Intervention Type
Device
Intervention Name(s)
Physica Posterior Stabilized Knee System
Intervention Description
Total knee prosthesis that sacrifices the posterior cruciate ligament (PCL) and replaces the functionality of the PCL with a post-cam mechanism.
Intervention Type
Device
Intervention Name(s)
Physica Cruciate Retaining Knee System with LMC Liner
Intervention Description
Total knee prosthesis with posterior cruciate ligament (PCL) preservation
Primary Outcome Measure Information:
Title
Implant Survivorship
Description
The primary endpoint is the definition of the implant survivorship of the study device to 10 years after the total knee replacement surgery.
Time Frame
10 years
Secondary Outcome Measure Information:
Title
American Knee Society Score (KSS) 2011
Description
Clinical performance assessment measured by overall pain and functionality from baseline to 10-year follow-up
Time Frame
10 years
Title
Patient-Reported Outcome Measures (PROMs)
Description
Patient-Reported Outcome Measures (PROMs) including patient satisfaction achievement from baseline to 10-year follow-up
Time Frame
10 years
Title
Radiographic Evaluation
Description
• Radiographic implant evaluation and stability assessment from baseline to 10-year follow-up
Time Frame
10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
22 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males and females of any race requiring a total knee replacement and suitable for the use of one of the configurations of the Physica system Age> 22 (skeletally mature) Patients who are suffering from non-inflammatory degenerative joint disease (NIDJD): including knee osteoarthritis, post-traumatic knee arthritis; or patients who are suffering from inflammatory arthritis; or patients that need correction of a functional deformity Suitable candidates for TKR who have undamaged and functional collateral ligaments Suitable candidates for TKR with Physica KR, CR, who have an undamaged and functional posterior cruciate ligament; or Physica LMC with or without a functioning posterior cruciate ligament or Physica PS with an absent or not-functioning posterior cruciate ligament and/or severe antero-posterior instability of the knee joint Patients who understand the conditions of the study and are willing and able to comply with the prescribed rehabilitation and to perform all scheduled follow-up visits Patients who have signed the Ethics Committee/IRB approved study-specific Informed Consent Form prior to the surgery Exclusion Criteria: Patients with severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function Patients with active or any suspected infection (on the affected knee or systemic) Previous partial knee replacement (unicompartimental, bicompartimental or patellofemoral joint replacement), patellectomy, high tibial osteotomy Patients with significant bone loss on femoral or tibial joint side Current treatment for malignant and/or life-threatening non-malignant disorders Patients with known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials Vascular insufficiency of lower limbs severe enough to interfere with the study evaluation Patients with bone stock compromised by disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis Patients with systemic or metabolic disorders leading to progressive bone deterioration which may impair fixation and stability of the implant Any concomitant disease and dependence that might affect the performance of the implanted prosthesis Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation (e.g. primary osteoporosis with significant bone loss, haemophilic disease, septicaemia, persistent acute or chronic osteomyelitis) Patients who have significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery and evaluation Patients who have neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint Any psychiatric illness that would prevent comprehension of the details and nature of the study Patients currently participating in any other surgical intervention studies or pain management studies Female patients who are pregnant, nursing, or planning a pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fabiana Pavan
Phone
+390432945357
Email
Fabiana.Pavan@limacorporate.com
First Name & Middle Initial & Last Name or Official Title & Degree
Federica Azzimonti
Email
federica.azzimonti@limacorporate.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fabiana Pavan
Organizational Affiliation
Limacorporate S.p.a
Official's Role
Study Director
Facility Information:
Facility Name
Eisenhower Desert Orthopedics Center - Harry and Diane Rinker Bldg
City
Rancho Mirage
State/Province
California
ZIP/Postal Code
92270
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Izzy Nunez
Phone
760-766-2540
Email
inunez@eisenhowerhealth.org
First Name & Middle Initial & Last Name & Degree
Wendy Monaco
Phone
7607662540
Email
wmonaco@eisenhowerhealth.org
First Name & Middle Initial & Last Name & Degree
Erik Schnaser, MD
First Name & Middle Initial & Last Name & Degree
Ghassan Boghosian, DO
Facility Name
The Orthopedics Clinic
City
Daytona Beach
State/Province
Florida
ZIP/Postal Code
32117
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mark Gillespy, MD
Phone
386-255-4596
First Name & Middle Initial & Last Name & Degree
Sherri Zicker
Phone
+1-386-255-4596
First Name & Middle Initial & Last Name & Degree
Mark Gillespy, MD
Facility Name
Rush Castle Orthopaedics
City
Aurora
State/Province
Illinois
ZIP/Postal Code
60504
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mark Schinsky, MD
Phone
630-978-3800
First Name & Middle Initial & Last Name & Degree
Renee Bergstrom
Phone
+1-630-978-3800
First Name & Middle Initial & Last Name & Degree
Mark Schinsky, MD
Facility Name
Syracuse Orthopedic Specialists
City
Syracuse
State/Province
New York
ZIP/Postal Code
13214
Country
United States
Individual Site Status
Completed
Facility Name
Joint Reconstructive Specialist
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73159
Country
United States
Individual Site Status
Completed

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Physica System Total Knee Replacement Registry Study

We'll reach out to this number within 24 hrs